Literature DB >> 33375694

Helicobacter pylori Virulence Factors-Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment.

Jacek Baj1, Alicja Forma2, Monika Sitarz3, Piero Portincasa4, Gabriella Garruti5, Danuta Krasowska6, Ryszard Maciejewski1.   

Abstract

Gastric cancer constitutes one of the most prevalent malignancies in both sexes; it is currently the fourth major cause of cancer-related deaths worldwide. The pathogenesis of gastric cancer is associated with the interaction between genetic and environmental factors, among which infection by Helicobacter pylori (H. pylori) is of major importance. The invasion, survival, colonization, and stimulation of further inflammation within the gastric mucosa are possible due to several evasive mechanisms induced by the virulence factors that are expressed by the bacterium. The knowledge concerning the mechanisms of H. pylori pathogenicity is crucial to ameliorate eradication strategies preventing the possible induction of carcinogenesis. This review highlights the current state of knowledge and the most recent findings regarding H. pylori virulence factors and their relationship with gastric premalignant lesions and further carcinogenesis.

Entities:  

Keywords:  BabA; DupA; Helicobacter pylori; OpiA; SabA; cagA; pathogenicity; urease; vacA; virulence factor

Mesh:

Substances:

Year:  2020        PMID: 33375694      PMCID: PMC7824444          DOI: 10.3390/cells10010027

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  378 in total

1.  Histological variety of gastric carcinoma and Helicobacter pylori cagA and vacA polymorphism.

Authors:  Natale Figura; Marcello Valassina; Elena Moretti; Carla Vindigni; Giulia Collodel; Francesca Iacoponi; Nicola Giordano; Francesco Roviello; Daniele Marrelli
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-09       Impact factor: 2.566

Review 2.  Peptic ulcer disease.

Authors:  Angel Lanas; Francis K L Chan
Journal:  Lancet       Date:  2017-02-25       Impact factor: 79.321

3.  Analysis of cell damage in Helicobacter pylori-associated gastritis.

Authors:  Kenji Noguchi; Katsuaki Kato; Takuya Moriya; Takashi Suzuki; Michiya Saito; Tohru Kikuchi; Jing Yang; Akira Imatani; Hitoshi Sekine; Syuichi Ohara; Takayoshi Toyota; Tooru Shimosegawa; Hironobu Sasano
Journal:  Pathol Int       Date:  2002-02       Impact factor: 2.534

4.  Helicobacter pylori vacA i region polymorphism but not babA2 status associated to gastric cancer risk in northwestern Iran.

Authors:  Batool Mottaghi; Reza Safaralizadeh; Morteza Bonyadi; Saeid Latifi-Navid; Mohammad Hossein Somi
Journal:  Clin Exp Med       Date:  2014-12-04       Impact factor: 3.984

5.  CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma.

Authors:  Atsuko Shibata; Julie Parsonnet; Teri A Longacre; Maria Isabel Garcia; Balaram Puligandla; R Eric Davis; Joseph H Vogelman; Norman Orentreich; Laurel A Habel
Journal:  Carcinogenesis       Date:  2002-03       Impact factor: 4.944

6.  The Helicobacter pylori protein HspB interferes with Nrf2/Keap1 pathway altering the antioxidant response of Ags cells.

Authors:  Elisabetta Buommino; Giovanna Donnarumma; Lucrezia Manente; Anna De Filippis; Francesco Silvestri; Salvatore Iaquinto; Maria Antonietta Tufano; Antonio De Luca
Journal:  Helicobacter       Date:  2012-07-11       Impact factor: 5.753

7.  Relationships between cagA, vacA, and iceA genotypes of Helicobacter pylori and DNA damage in the gastric mucosa.

Authors:  Marcelo S P Ladeira; Maria A M Rodrigues; Daisy M F Salvadori; Pedro Padulla Neto; Pedro Achilles; Mauro M Lerco; Paulo A Rodrigues; Irio Gonçalves; Dulciene M M Queiroz; Dértia V Freire-Maia
Journal:  Environ Mol Mutagen       Date:  2004       Impact factor: 3.216

8.  Evidence for conserved function of γ-glutamyltranspeptidase in Helicobacter genus.

Authors:  Mirko Rossi; Christian Bolz; Joana Revez; Sundus Javed; Nahed El-Najjar; Florian Anderl; Heidi Hyytiäinen; Pia Vuorela; Markus Gerhard; Marja-Liisa Hänninen
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

9.  Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project.

Authors:  C A González; F Megraud; A Buissonniere; L Lujan Barroso; A Agudo; E J Duell; M C Boutron-Ruault; F Clavel-Chapelon; D Palli; V Krogh; A Mattiello; R Tumino; C Sacerdote; J R Quirós; E Sanchez-Cantalejo; C Navarro; A Barricarte; M Dorronsoro; K-T Khaw; N Wareham; N E Allen; K K Tsilidis; H Bas Bueno-de-Mesquita; S M Jeurnink; M E Numans; P H M Peeters; P Lagiou; E Valanou; A Trichopoulou; R Kaaks; A Lukanova-McGregor; M M Bergman; H Boeing; J Manjer; B Lindkvist; R Stenling; G Hallmans; L M Mortensen; K Overvad; A Olsen; A Tjonneland; K Bakken; V Dumeaux; E Lund; M Jenab; I Romieu; D Michaud; T Mouw; F Carneiro; C Fenge; E Riboli
Journal:  Ann Oncol       Date:  2011-09-14       Impact factor: 32.976

10.  Creation and Initial Characterization of Isogenic Helicobacter pylori CagA EPIYA Variants Reveals Differential Activation of Host Cell Signaling Pathways.

Authors:  Dacie R Bridge; Faith C Blum; Sungil Jang; Jinmoon Kim; Jeong-Heon Cha; D Scott Merrell
Journal:  Sci Rep       Date:  2017-09-08       Impact factor: 4.379

View more
  26 in total

1.  Targeting cPLA2α inhibits gastric cancer and augments chemotherapy efficacy via suppressing Ras/MEK/ERK and Akt/β-catenin pathways.

Authors:  Yingying Liao; Wei Chen; Wei Shi; Huolong Zha
Journal:  Cancer Chemother Pharmacol       Date:  2021-07-13       Impact factor: 3.333

2.  Prevalence of tumor necrosis factor alpha inducing protein (tipα) gene of Helicobacter pylori and its association with upper gastrointestinal diseases in India.

Authors:  Shweta Mahant; Shubham Mehra; Ayushi Chhawchharia; Bipul Chandra Karmakar; Sangita Paul; Asish Kumar Mukhopadhyay; Sudeep Bose; Kunal Das; Rajashree Das
Journal:  3 Biotech       Date:  2021-04-30       Impact factor: 2.406

3.  Antagonistic Activities of Lactobacillus rhamnosus JB3 Against Helicobacter pylori Infection Through Lipid Raft Formation.

Authors:  Anh Duy Do; Chiu-Hsian Su; Yuan-Man Hsu
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

Review 4.  Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms.

Authors:  Hyelnaya Cletus Sharndama; Ifeanyi Elibe Mba
Journal:  Braz J Microbiol       Date:  2022-01-06       Impact factor: 2.476

Review 5.  Helicobacter pylori Pathogenicity Islands and Giardia lamblia Cysteine Proteases in Role of Coinfection and Pathogenesis.

Authors:  Mihret Tilahun; Alemu Gedefie; Chernet Belayhun; Zenawork Sahle; Admasu Abera
Journal:  Infect Drug Resist       Date:  2022-01-06       Impact factor: 4.003

Review 6.  Evolution of Diagnostic Methods for Helicobacter pylori Infections: From Traditional Tests to High Technology, Advanced Sensitivity and Discrimination Tools.

Authors:  Alexandra Ioana Cardos; Adriana Maghiar; Dana Carmen Zaha; Ovidiu Pop; Luminita Fritea; Florina Miere Groza; Simona Cavalu
Journal:  Diagnostics (Basel)       Date:  2022-02-16

Review 7.  The Effects and Mechanisms of Flavonoids on Cancer Prevention and Therapy: Focus on Gut Microbiota.

Authors:  Man Wang; Fei Yu; Yuan Zhang; Wenguang Chang; Meng Zhou
Journal:  Int J Biol Sci       Date:  2022-01-24       Impact factor: 6.580

Review 8.  Effect of Clostridium butyricum on Gastrointestinal Infections.

Authors:  Tadashi Ariyoshi; Mao Hagihara; Motomichi Takahashi; Hiroshige Mikamo
Journal:  Biomedicines       Date:  2022-02-18

Review 9.  The Roles of Phospholipase A2 in Phagocytes.

Authors:  Deepti Dabral; Geert van den Bogaart
Journal:  Front Cell Dev Biol       Date:  2021-06-10

Review 10.  Advances in the Aetiology & Endoscopic Detection and Management of Early Gastric Cancer.

Authors:  Darina Kohoutova; Matthew Banks; Jan Bures
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.